Stereotaxis Inc Stock price Nasdaq
Equities
US85916J4094
Advanced Medical Equipment & Technology
Financials (USD)
Sales 2024 * | 30.6M | Sales 2025 * | 43.54M | Capitalization | 196M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | -14M | EV / Sales 2024 * | 6.4 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.5 x |
P/E ratio 2024 * |
-11.4
x | P/E ratio 2025 * |
-15
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.92% |
Latest transcript on Stereotaxis Inc
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 16-09-28 | |
Director of Finance/CFO | 55 | 02-12-31 | |
Laura Garth
LAW | General Counsel | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Messey
BRD | Director/Board Member | 78 | 05-04-30 |
Chief Executive Officer | 57 | 16-09-28 | |
Nathan Fischel
BRD | Director/Board Member | 68 | 17-02-02 |
1st Jan change | Capi. | |
---|---|---|
+9.50% | 222B | |
+7.95% | 185B | |
+18.30% | 141B | |
+18.47% | 100B | |
+7.83% | 68.36B | |
+25.32% | 57.52B | |
-3.69% | 46.84B | |
+4.66% | 42.64B | |
+15.12% | 29.09B |